GENENTA SCIENCE(SP.ADR)/1 (K5F) — Financial Flexibility Index
GENENTA SCIENCE(SP.ADR)/1 (K5F) has a Financial Flexibility Index of -0.68x as of December 2025. Free cash flow of €-6.86 Million (operating CF €-6.87 Million minus capex €7.62K) represents -1% of total liabilities (€10.05 Million). Check asset resilience ratio of GENENTA SCIENCE(SP.ADR)/1 to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GENENTA SCIENCE(SP.ADR)/1 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for GENENTA SCIENCE(SP.ADR)/1 across 5 annual periods. See K5F working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for GENENTA SCIENCE(SP.ADR)/1 (2021–2025)
Year-by-year free cash flow to debt coverage for GENENTA SCIENCE(SP.ADR)/1. For the full company profile including market capitalisation, see K5F stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.68x | €-6.86 Million | €-6.87 Million | €10.05 Million | ▲ +74.5% |
| 2024 | -2.68x | €-6.24 Million | €-6.24 Million | €2.33 Million | ▲ +54.2% |
| 2023 | -5.84x | €-11.19 Million | €-11.21 Million | €1.91 Million | ▼ -81.8% |
| 2022 | -3.21x | €-7.39 Million | €-7.42 Million | €2.30 Million | ▲ +46.1% |
| 2021 | -5.96x | €-6.95 Million | €-6.96 Million | €1.17 Million | — |